Regeneron CSO George Yancopoulos (L) and CEO Len Schleifer at a groundbreaking for its new Tarrytown, NY facility, June 2022 (Lev Radin/Pacific Press/LightRocket via Getty Images)
In showdown with Roche, Regeneron gears up for potential Eylea expansion amid Covid decline
Regeneron faced a substantial slump in overall revenue last year, but the focus still remains on some of its biggest blockbusters.
The pharma with several …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
